fredun-pharmaceuticals-ltd
Home
Fredun Pharmaceuticals Ltd
null Share Price
BSE:
NSE:
null Share Price
BSE:
NSE:
Pharmaceuticals
Small Cap
₹-
0 (0%)
Market Cap
₹347.08 Cr
PE Ratio
19.62
Fredun Pharmaceuticals Ltd Performance
▲
▲
▲
▲
Fredun Pharmaceuticals Ltd Fundamentals
Fredun Pharmaceuticals Ltd Delivery and Volume
About Fredun Pharmaceuticals Ltd
Incorporated in 1987 as a private limited company, Fredun Pharmaceuticals (FPL) was converted into a public limited company in Mar.'94. The Company was promoted by Nariman Medhora and Daulat N Medhora. The promoters initially established D N Pharma, a proprietary firm, for the manufacture and export
| Name | Designation |
|---|---|
| Daulat N Medhora | WTD & Joint Managing Director |
| Nariman B Medhora | Executive Director |
| Aspi N Raimalwala | Non-Exec. & Independent Dir. |
| Fredun N Medhora | Managing Director & CFO |
| Rohinton Kanga | Non-Exec. & Independent Dir. |
| Jinkal Shah | Company Sec. & Compli. Officer |
| Daisy Dsouza | Additional Director |
News and Events...
Top Gainers Today
View All
Top Losers Today
View All
Fredun Pharmaceuticals Ltd FAQs
How do I Buy Fredun Pharmaceuticals Ltd Shares?
By opening a demat account and having your KYC papers confirmed online, you may simply purchase Fredun Pharmaceuticals Ltd shares in BlinkX.
What is the Share Price of Fredun Pharmaceuticals Ltd?
The share price of any stock is volatile and changes during the day due to a variety of variables. Fredun Pharmaceuticals Ltd's share price is ₹738.6 as of 2024-12-13.
What is the PE ratio of Fredun Pharmaceuticals Ltd?
Fredun Pharmaceuticals Ltd's P/E ratio is 19.62 times as of 2024-12-13.
What is the PB ratio of Fredun Pharmaceuticals Ltd?
Fredun Pharmaceuticals Ltd's most recent financial reports indicate a price-to-book ratio of 2.65, showing the company's stock market valuation in relation to the value of its real assets.
What is the Market Cap of Fredun Pharmaceuticals Ltd?
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Fredun Pharmaceuticals Ltd's market capitalization is ₹347.08 Cr as on 2024-12-13.
What is the ROE of Fredun Pharmaceuticals Ltd?
The current financial records of Fredun Pharmaceuticals Ltd show a 14.34% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
What is the Total Asset of Fredun Pharmaceuticals Ltd?
According to Fredun Pharmaceuticals Ltd's most recent financial filings, the company has a total asset value of ₹256.39, which includes current and non-current assets such as inventory, cash, properties, and equipment.
What is the 52-week high and Low of Fredun Pharmaceuticals Ltd?
The 52-week high/low price of a Fredun Pharmaceuticals Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Fredun Pharmaceuticals Ltd's 52-week high and low as of 2024-12-13 are ₹750 and ₹708.45, respectively.
